Feds Want GSK VP To Testify In Wellbutrin Case

Law360, New York (April 20, 2011, 8:42 PM EDT) -- Prosecutors asked a Maryland federal judge Tuesday to force a GlaxoSmithKline PLC vice president to testify in the criminal case against a former GSK attorney accused of lying to health regulators about the marketing of antidepressant Wellbutrin.

Testimony from James Millar, GSK's vice president of strategic pricing, contracting and marketing, may help convict former GSK associate general counsel Lauren Stevens, and Millar may be reluctant to testify for fear of incriminating himself, prosecutors argue. 

Stevens is accused of interfering with a U.S. Food and Drug Administration...
To view the full article, register now.




Case Information

Case Title

USA v. Stevens

Case Number




Nature of Suit

Date Filed

November 8, 2010

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.